T
Thomas Haack
Researcher at Novartis
Publications - 14
Citations - 268
Thomas Haack is an academic researcher from Novartis. The author has contributed to research in topics: Dispersant & Peptide. The author has an hindex of 5, co-authored 14 publications receiving 256 citations. Previous affiliations of Thomas Haack include University of Pittsburgh & University of Lausanne.
Papers
More filters
Journal ArticleDOI
Serine derived oxazolidines as secondary structure disrupting, solubilizing building-blocks in peptide-synthesis
Thomas Haack,Manfred Mutter +1 more
TL;DR: The incorporation of serine as oxazolidine protected “pseudo proline “in a host peptide results in the disruption of secondary structure formation thus increasing the solvation of the peptide chain.
Journal ArticleDOI
Recognition and Stabilization of an α-Helical Peptide by a Synthetic Receptor
Journal ArticleDOI
Phthalazine PDE IV inhibitors: conformational study of some 6-methoxy-1,4-disubstituted derivatives.
Thomas Haack,Raimondo Fattori,Mauro Napoletano,Franco Pellacini,Giovanni Fronza,Giuseppina Raffaini,Fabio Ganazzoli +6 more
TL;DR: Compound 3 bearing the thiazole ring at C4 displays the major biological activity, thus suggesting that a planar and rather rigid conformation of the pentacycle should favour the PDE IV inhibition capacity of this class of compounds.
Patent
4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations
Mauro Napoletano,Thomas Haack,Silvia Macecchini,Lara Pippo,Jean-Dominique Moriggi,Gabriele Morazzoni,Allievi Leopoldo,Ermanno Moriggi,Franco Pellacini +8 more
TL;DR: In this paper, the meanings of compounds of formula (I) have been defined in the specification, the N-oxidized derivatives of the compounds, the pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them and the use thereof as phosphodiesterase 4 inhibitors for the treatment of allergic and inflammatory pathologies, such as ARDS, COPD, asthma and allergic rhinitis are described.
Patent
Process for drying concrete dispersants
TL;DR: A process for the production of a solid dispersant for a hydraulically binding composition includes the steps of: providing at least one first polymer, which is a comb polymer having a polymer backbone comprising carboxyl groups; providing a second polymer which are a condensate of, at least, an aromatic compound and formaldehyde; or a lignosulfonate; preparing an aqueous solution comprising the first and the second polymer; and spray-drying the aiquous solution to obtain the solid dispersent.